As we come within a stone’s throw of Nov. 5, we can’t help but wonder if and how the election outcome will impact health care policy, and cancer policy in particular. Although health care has not been a central issue in the 2024 presidential campaign, the election’s outcome has the potential to affect a wide […]
The WU-KONG1 trial found that sunvozertinib yielded a best ORR of 53.3% and a cORR of 44.9% in patients with NSCLC harboring EGFR exon20ins mutations.
The AACR Cancer Progress Report 2024 detailed the connection between alcohol consumption and the increased risk of certain cancers.
According to results from the phase 1b/2 RC48-C014 study, the addition of 2 mg/kg of disitamab vedotin to toripalimab is preferable to 1.5 mg/kg among…
This study presents findings from a cost and activity analysis of a citywide hospital-based patient navigation program to engage women in timely breast cancer treatment…
The OSUCCC – James announces the following awards, honors, grants and more that were recently given to the organization, teams or individuals.
Regular physical activity prior to a cancer diagnosis lowered a patient’s risk for disease progression and death, according to study findings.Even small amounts of physical…
Fixed-duration zanubrutinib/venetoclax elicited responses in patients with relapsed/refractory chronic lymphocytic leukemia.
Abenacianine, a tumor-targeted fluorescent imaging agent, received fast track designation from the FDA after demonstrating its safety and efficacy in visualizing lung tumors in a…
Adults aged 70 or over account for more than a third of all new cancer diagnoses globally [1]. Despite continuous efforts in the last decades,…
The FDA released a draft guidance document detailing their interpretation of when a confirmatory clinical trial for an accelerated approval is underway.
